Longevity Medicine in Mallorca: A Medical Approach to Living Healthier for Longer

Longevity medicine is attracting increasing attention from people who want to understand their health before disease becomes established.

But longevity medicine should not be confused with promises of immortality, reversing ageing or pursuing every new anti-ageing treatment available.

At its most clinically meaningful, longevity medicine asks a more practical question:

What can we understand about your current health today that may help protect your health, function and quality of life in the years ahead?

In Mallorca, Dr. Indhira Ghyssaert approaches longevity medicine through preventive healthcare, personalised medical assessment, identification of modifiable risk factors and evidence-informed clinical decision-making.

The objective is not simply to live longer.

It is to protect healthspan: the years of life spent with good physical function, metabolic health, cognitive health and independence.

Longevity Medicine Mallorca: In One Minute

A physician-led longevity medicine assessment in Mallorca with Dr. Indhira Ghyssaert may consider different aspects of health depending on the individual patient.

These can include:

Cardiovascular risk.

Blood pressure.

Metabolic health.

Glucose regulation.

Insulin resistance.

Lipid profile.

Body composition.

Physical activity and fitness.

Nutrition.

Sleep.

Stress and recovery.

Hormonal health where clinically relevant.

Nutritional deficiencies.

Family history.

Lifestyle risk factors.

Age-appropriate preventive screening.

Relevant laboratory biomarkers.

Existing medical conditions.

The purpose is not to perform every available test.

It is to identify which information is actually useful for understanding an individual's health and potential future risk.

From there, Dr. Ghyssaert can develop a personalised medical strategy around the areas where meaningful intervention may be possible.

What Is Longevity Medicine?

Longevity medicine is an emerging area of healthcare focused on understanding and potentially modifying factors associated with long-term health, disease risk and functional ageing.

It brings together concepts from several established areas of medicine, including:

Preventive medicine.

General medicine.

Cardiovascular prevention.

Metabolic health.

Nutrition.

Exercise medicine.

Sleep medicine.

Lifestyle medicine.

Risk-factor management.

Age-appropriate screening.

The central objective is not simply to treat disease once it appears.

It is to identify opportunities to preserve health earlier.

For Dr. Indhira Ghyssaert, this means looking at the individual patient rather than applying the same longevity protocol to everyone.

Longevity Is Not the Same as Anti-Ageing

The terms are frequently used interchangeably.

They should not necessarily be.

Ageing is a fundamental biological process.

Modern medicine can identify and treat many conditions associated with increasing age, and lifestyle interventions can substantially influence the risk of several chronic diseases.

But this is different from claiming that medicine can simply reverse human ageing.

Dr. Indhira Ghyssaert does not approach longevity medicine as a promise of age reversal.

Her approach is built around a more medically grounded objective:

Understand health.

Identify risk.

Detect relevant problems early.

Improve modifiable factors.

Protect function.

Support healthier ageing.

This distinction is central to her approach to longevity medicine in Mallorca.

What Is Healthspan?

Lifespan describes how long someone lives.

Healthspan describes how long someone remains in relatively good health and function.

This distinction matters.

Imagine two people who both live to 90.

One remains physically active and independent well into later life.

The other develops multiple chronic diseases considerably earlier and spends many years with reduced function.

Their lifespan may be similar.

Their healthspan is not.

For this reason, Dr. Ghyssaert's approach to longevity medicine focuses not only on years of life but on the quality and functional capacity of those years.

The objective is not to predict exactly how long someone will live.

It is to identify areas of health where meaningful preventive action may be possible.

Why Longevity Medicine Is Growing

Medicine has traditionally been very effective at responding to established disease.

A patient develops symptoms.

A diagnosis is made.

Treatment begins.

That model remains essential.

But many of the conditions responsible for long-term illness develop gradually.

Cardiovascular disease.

Type 2 diabetes.

Hypertension.

Metabolic dysfunction.

Loss of muscle and physical capacity.

Certain nutritional problems.

Some age-associated conditions.

Risk can accumulate for years before significant symptoms appear.

This creates an opportunity for preventive medicine.

Instead of waiting exclusively for disease to announce itself, Dr. Ghyssaert's longevity approach can also ask:

What risks are already visible?

Which ones can potentially be modified?

What should be monitored?

What preventive measures are appropriate for this particular patient?

That is where longevity medicine can become clinically meaningful.

Longevity Medicine Is Not About Doing More Tests

Modern healthcare can measure an extraordinary number of biomarkers.

That can be valuable.

It can also create a misconception:

More data = better medicine.

Not necessarily.

A test becomes clinically useful when the result can meaningfully contribute to understanding risk, diagnosis, prevention or management.

Ordering hundreds of biomarkers without a clear clinical question can produce enormous amounts of information without necessarily improving patient care.

It may also identify incidental abnormalities that require further interpretation.

For this reason, Dr. Indhira Ghyssaert's approach to longevity medicine in Mallorca is not based on obtaining the largest possible laboratory panel.

It is based on determining which information may actually be relevant to the individual patient.

Biomarkers and Longevity Medicine

A biomarker is a measurable biological characteristic that can provide information about a physiological or pathological process.

Depending on the patient, conventional biomarkers can provide valuable information about areas such as:

Blood glucose regulation.

Lipid metabolism.

Kidney function.

Liver function.

Blood-cell status.

Thyroid function.

Inflammation in selected contexts.

Nutritional status.

Other clinically relevant parameters.

More specialised testing may sometimes be considered when there is an appropriate reason.

But biomarkers should support clinical reasoning rather than replace it.

A laboratory report does not understand the patient.

Dr. Ghyssaert interprets results within the context of factors such as:

Age.

Sex.

Symptoms.

Medical history.

Medication.

Family history.

Lifestyle.

Previous results.

Other risk factors.

This context is what transforms data into useful medical information.

Do You Need 1,000 Biomarkers to Practise Longevity Medicine?

Not necessarily.

Large biomarker panels can generate extensive information.

But the number of measurements is not itself a measure of medical quality.

A smaller set of clinically meaningful tests may sometimes provide more actionable information than hundreds of biomarkers obtained without a specific purpose.

Dr. Indhira Ghyssaert considers questions such as:

Why are we measuring this?

What does the result tell us?

How clinically useful is the marker?

Would the result potentially change what we recommend?

This is particularly important in longevity medicine, where rapidly developing commercial technologies can sometimes move faster than the evidence supporting their routine clinical use.

Biological Age vs Chronological Age

Chronological age is straightforward.

It is the number of years since birth.

The concept of biological age attempts to describe how biological characteristics compare with patterns typically associated with ageing.

Different commercial tests attempt to estimate biological age using different combinations of biomarkers or molecular measurements.

This is scientifically interesting.

However, patients should understand an important limitation:

There is no single universally accepted biological-age measurement that completely defines how quickly an individual is ageing.

Different tests may measure different aspects of biology and may produce different estimates.

For this reason, Dr. Ghyssaert does not treat a biological-age result as an absolute prediction of lifespan or future health.

It can be information to interpret—not a complete definition of the patient.

Can You Reverse Your Biological Age?

Claims about reversing biological age should be interpreted carefully.

Some measurements used to estimate biological ageing may change in response to health or lifestyle interventions.

That does not necessarily mean the entire human ageing process has literally been reversed.

Dr. Indhira Ghyssaert prefers to focus on areas of health where there is a meaningful clinical rationale for intervention.

For example:

Improve blood pressure when elevated.

Improve metabolic health.

Address smoking.

Increase physical activity.

Improve nutrition.

Protect muscle and physical capacity.

Address clinically important sleep problems.

Manage established cardiovascular risk.

These changes may be considerably more meaningful for long-term health than pursuing an impressive number on a commercial biological-age test.

Longevity Medicine and Preventive Medicine

There is substantial overlap between longevity medicine and preventive medicine.

Preventive medicine aims to reduce the probability or impact of disease through appropriate interventions.

This may include:

Screening.

Vaccination.

Blood-pressure management.

Cardiovascular risk assessment.

Metabolic assessment.

Cancer prevention and screening.

Lifestyle intervention.

Nutrition.

Exercise.

Smoking cessation.

Early identification of disease.

Dr. Ghyssaert's approach to longevity medicine builds on these foundations while taking a broader view of long-term function and healthy ageing.

The fundamentals of preventive healthcare should not be abandoned simply because newer technologies are available.

The Foundations of Longevity

Some of the most important influences on long-term health are remarkably familiar.

For Dr. Indhira Ghyssaert, longevity medicine should therefore begin with the foundations rather than immediately moving toward experimental interventions.

Physical Activity and Longevity

Regular physical activity is associated with broad health benefits.

Both cardiovascular fitness and muscular strength matter.

Movement should therefore be considered a central component of healthy ageing rather than an optional wellness activity.

A personalised longevity assessment may consider:

Current physical activity.

Sedentary time.

Cardiovascular exercise.

Strength training.

Mobility.

Individual limitations.

Previous injuries.

Medical conditions affecting exercise.

The objective is not to prescribe the same exercise programme to everyone.

It is to understand what level and type of physical activity is appropriate for the individual.

Muscle, Strength and Healthy Ageing

Maintaining muscle mass and strength becomes increasingly important with age.

Muscle contributes to:

Physical independence.

Mobility.

Metabolic health.

Balance.

Functional capacity.

The ability to tolerate illness and periods of inactivity.

For this reason, Dr. Ghyssaert considers physical function and body composition potentially relevant components of a longevity strategy.

The number on a scale alone provides only limited information about long-term physical health.

Metabolic Health and Longevity

Metabolic health is one of the central areas of preventive and longevity medicine.

Glucose regulation, insulin sensitivity and body composition can influence long-term health.

Metabolic dysfunction can develop gradually, sometimes before a person recognises obvious symptoms.

A person may feel generally healthy while developing:

Insulin resistance.

Prediabetes.

Abnormal lipid patterns.

Hypertension.

Increasing visceral adiposity.

Other cardiovascular risk factors.

This is one reason why longevity medicine is not exclusively for people who feel unwell.

Preventive medical assessment may sometimes identify modifiable risks before significant symptoms occur.

Insulin Resistance and Healthy Ageing

Insulin is essential for normal metabolism.

Insulin resistance describes reduced responsiveness of tissues to insulin and can be associated with metabolic dysfunction.

Over time, insulin resistance may contribute to progression toward prediabetes and type 2 diabetes in susceptible individuals.

However, Dr. Ghyssaert does not consider insulin resistance a fashionable label that should be applied to every patient.

Assessment should be based on appropriate clinical and metabolic information.

Where relevant, intervention may involve nutrition, physical activity, body-composition improvement and management of associated risk factors.

Cardiovascular Health and Longevity

Cardiovascular prevention remains one of the most important components of long-term health.

When discussing longevity, it can be tempting to focus exclusively on emerging technologies, novel biomarkers and new interventions.

But established cardiovascular risk factors remain highly relevant.

Depending on the individual, Dr. Indhira Ghyssaert may consider:

Blood pressure.

Lipid profile.

Smoking.

Glucose metabolism.

Family history.

Physical activity.

Body composition.

Existing cardiovascular disease.

Other relevant clinical factors.

The appropriate assessment depends on the individual patient's age, history and overall risk profile.

A responsible longevity doctor in Mallorca should therefore be at least as interested in established cardiovascular prevention as in emerging longevity science.

Nutrition and Longevity

Nutrition influences multiple aspects of health.

But longevity nutrition should not be reduced to a single universal diet.

Different patients have different requirements.

Relevant considerations may include:

Energy intake.

Protein intake.

Fibre.

Micronutrient adequacy.

Metabolic health.

Dietary preferences.

Existing medical conditions.

Body composition.

Physical activity.

Nutritional deficiencies.

Dr. Ghyssaert's approach is to consider nutrition within the broader medical picture rather than assuming that one diet represents the ideal longevity diet for everyone.

Sleep and Healthy Ageing

Sleep is another fundamental component of health.

Persistent poor sleep can affect wellbeing, cognitive function and multiple physiological systems.

Where relevant, Dr. Ghyssaert's longevity assessment may therefore consider:

Sleep duration.

Sleep quality.

Difficulty falling asleep.

Frequent awakening.

Daytime fatigue.

Snoring or other symptoms potentially suggesting sleep-related disorders.

The objective is not simply to prescribe supplements for sleep.

It is to understand whether an identifiable sleep problem deserves further attention.

Stress, Lifestyle and Recovery

Chronic psychological stress can influence behaviour, sleep and overall wellbeing.

But stress should not become a vague explanation for every symptom or abnormal biomarker.

Dr. Ghyssaert considers stress within the broader clinical context.

Recovery may involve:

Adequate sleep.

Nutrition.

Physical recovery.

Appropriate exercise.

Psychological wellbeing.

Work-life factors.

Management of underlying medical conditions.

The relevant combination differs from one patient to another.

Longevity Medicine and Inflammation

Inflammation is another term frequently used in longevity medicine.

Inflammatory processes play roles in many diseases and are also part of normal immune function.

But the concept is often oversimplified.

A patient should not automatically be told that vague symptoms mean their body is "inflamed."

Nor should every inflammatory biomarker be interpreted in isolation.

When inflammation is clinically relevant, Dr. Ghyssaert's question is not simply:

“How can we lower inflammation?”

It is:

“Why might this marker be abnormal, and what does it mean in this patient's clinical context?”

Possible explanations vary enormously.

Understanding the cause is more meaningful than simply trying to optimise a number.

Hormonal Health and Longevity

Hormones influence numerous physiological systems.

Thyroid hormones.

Sex hormones.

Insulin.

Cortisol.

Other endocrine pathways.

Hormonal assessment may be appropriate when symptoms, age, medical history or other clinical factors justify it.

But Dr. Indhira Ghyssaert does not consider longevity medicine synonymous with hormone optimisation.

Laboratory values should not automatically become targets to maximise simply because they change with age.

Hormonal treatment requires individual medical assessment, appropriate indications and consideration of potential risks and benefits.

Testosterone and Longevity

Testosterone has become particularly prominent in longevity and anti-ageing marketing.

This deserves caution.

Testosterone is an important hormone.

Clinically significant testosterone deficiency may require appropriate medical evaluation and, in selected patients, treatment.

But testosterone therapy should not be presented as a universal longevity intervention for men simply because testosterone levels may change with age.

Dr. Ghyssaert considers symptoms, appropriate laboratory evaluation, medical history, contraindications and individual risk-benefit considerations when hormonal treatment is relevant.

The objective is not to maximise testosterone.

It is to determine whether a genuine medical issue exists and manage it appropriately.

Menopause and Healthy Ageing

Menopause represents an important transition in women's health.

Changes in reproductive hormones can influence symptoms, bone health and other aspects of wellbeing.

A longevity-focused medical assessment may consider menopause within the broader context of:

Cardiovascular health.

Bone health.

Metabolic health.

Sleep.

Body composition.

Symptoms.

Sexual health.

Individual medical history.

Where treatment is considered, Dr. Ghyssaert approaches the decision individually rather than applying a universal anti-ageing protocol.

Bone Health and Longevity

Healthy ageing is not only about avoiding cardiovascular or metabolic disease.

Bone health matters enormously for maintaining independence later in life.

Loss of bone density can increase fracture risk.

And fractures in older age can have significant consequences for mobility and independence.

Depending on age and individual risk factors, Dr. Ghyssaert may consider:

Nutrition.

Physical activity.

Resistance exercise.

Vitamin D status where clinically relevant.

Calcium intake.

Menopausal status.

Medication.

Family history.

Appropriate bone-health assessment.

Longevity medicine should therefore consider the musculoskeletal system alongside metabolic and cardiovascular health.

Brain Health and Longevity

Cognitive health is understandably one of the greatest concerns people have about ageing.

There is no single test, supplement or treatment capable of guaranteeing protection against cognitive decline.

However, many aspects of general health are also relevant to brain health.

Cardiovascular risk.

Physical activity.

Sleep.

Metabolic health.

Smoking.

Alcohol.

Social engagement.

Hearing.

Management of relevant medical conditions.

For Dr. Ghyssaert, a responsible longevity strategy should therefore avoid presenting brain health as something that can be reduced to one supplement, infusion or biomarker.

Longevity Medicine Is Not a Supplement Programme

Supplements can have appropriate roles.

Correcting nutritional deficiencies can matter.

Certain supplements have specific established uses.

But longevity medicine should not become synonymous with taking dozens of capsules every morning.

When reviewing supplements, Dr. Ghyssaert considers questions such as:

Why is this being taken?

What evidence supports its use?

Is the dose appropriate?

Could it interact with medication?

Is it still necessary?

Periodic review matters because a personalised longevity strategy should evolve with the patient.

Longevity Medicine Is Not an IV Programme

The same principle applies to intravenous therapy.

IV treatment may have appropriate applications in selected circumstances.

But Dr. Indhira Ghyssaert does not define longevity medicine through regular intravenous infusions.

A patient does not automatically become healthier simply because more treatments are delivered intravenously.

The foundations of long-term health remain broader:

Prevention.

Risk-factor management.

Nutrition.

Physical activity.

Sleep.

Metabolic health.

Cardiovascular health.

Appropriate screening.

Medical follow-up.

Intravenous therapy, where medically appropriate, is only one potential intervention within a much larger medical picture.

Precision Medicine and Longevity

The term precision medicine describes an ambition to make healthcare increasingly specific to individual characteristics.

This can include clinical history, biomarkers, risk factors and, in selected contexts, molecular or genetic information.

The concept is highly relevant to longevity medicine.

But precision should not be confused with complexity.

A recommendation is not more personalised simply because it involves more tests.

Sometimes the most precise recommendation may be remarkably straightforward:

Improve elevated blood pressure.

Increase physical activity.

Address excess visceral adiposity.

Stop smoking.

Correct a genuine deficiency.

Improve sleep.

Treat an established medical condition appropriately.

The value lies in identifying which intervention matters for which patient.

Personalised Longevity Medicine in Mallorca

Two people of the same chronological age can have very different health profiles.

One may have excellent cardiovascular fitness but significant family cardiovascular risk.

Another may have normal body weight but impaired glucose regulation.

Another may have excellent metabolic health but poor sleep and reduced muscle strength.

Another may already have several established medical conditions requiring appropriate management.

This is why Dr. Indhira Ghyssaert does not approach longevity medicine in Mallorca through a completely standardised protocol.

The objective is to understand the individual patient first.

What Does a Longevity Doctor Actually Do?

A longevity doctor should do more than order biomarkers.

The physician's role is to integrate information.

For Dr. Indhira Ghyssaert, this may involve:

Reviewing medical history.

Understanding family history.

Evaluating symptoms.

Reviewing medication and supplements.

Assessing existing diagnoses.

Considering lifestyle.

Reviewing previous investigations.

Identifying relevant risk factors.

Selecting appropriate tests.

Interpreting results in context.

Discussing prevention.

Developing priorities.

Following progress over time.

Recognising when specialist referral is appropriate.

The value lies in medical interpretation and decision-making—not simply in producing data.

English-Speaking Longevity Doctor in Mallorca

Mallorca is home to a large international community and receives visitors from around the world.

For international patients, being able to discuss complex health questions clearly in English can be particularly valuable.

Dr. Indhira Ghyssaert provides English-speaking medical consultations in Mallorca and approaches longevity through personalised assessment, preventive medicine and evidence-informed healthcare.

Some patients seek consultation because they have specific health concerns.

Others may feel well but want a more structured understanding of their current health and long-term risk factors.

Both can be reasonable starting points.

The assessment can then be adapted to the individual rather than forcing every patient through the same longevity protocol.

Dr. Indhira Ghyssaert's Approach to Longevity Medicine in Mallorca

Dr. Indhira Ghyssaert approaches longevity medicine through a straightforward clinical philosophy:

Understand the patient before designing the strategy.

Identify established health risks.

Investigate where clinically useful.

Distinguish meaningful biomarkers from interesting data.

Prioritise interventions according to potential importance.

Use established preventive medicine as the foundation.

Consider emerging longevity approaches with appropriate scientific caution.

Review progress over time.

And importantly:

Do not promise to reverse ageing.

The objective is more meaningful than that.

It is to help patients understand their health and make informed decisions that may support better long-term health, physical function and quality of life.

Clinical Principle

Longevity medicine should not be measured by how many biomarkers are tested or how many treatments are prescribed. Its value lies in identifying meaningful health risks and helping the individual act on what can reasonably be changed.

Longevity Medicine Mallorca: From Lifespan to Healthspan

The most useful question in longevity medicine may not be:

“How can I live to 120?”

It may be:

“What can I do today to increase my chances of remaining healthy, active and independent as I grow older?”

That question changes the entire approach.

It moves longevity away from extraordinary promises and toward:

Prevention.

Cardiovascular health.

Metabolic health.

Physical capacity.

Nutrition.

Sleep.

Appropriate screening.

Early identification of disease.

Risk-factor management.

Personalised medical care.

For Dr. Indhira Ghyssaert, this is the foundation of physician-led longevity medicine in Mallorca.

What Does a Longevity Medicine Assessment Actually Look At?

A longevity medicine assessment in Mallorca should not begin with a predetermined package of tests or treatments.

It should begin with the individual.

Dr. Indhira Ghyssaert's approach is to understand the patient's current health, medical history, lifestyle, family history, symptoms and objectives before deciding which areas deserve further attention.

Two people asking for a longevity assessment may require very different approaches.

One patient may have a strong family history of cardiovascular disease.

Another may be concerned about diabetes because of increasing blood glucose.

Another may want to understand persistent fatigue.

Another may be entering menopause and thinking more seriously about bone, metabolic and cardiovascular health.

Another may feel completely well but want a structured preventive health assessment.

The purpose of personalised longevity medicine is therefore not to place every patient through the same protocol.

It is to determine:

Where are the meaningful risks?

What information do we already have?

What additional information would actually be useful?

What can reasonably be improved?

What should be monitored over time?

The Starting Point: Your Medical History

Before advanced biomarkers, biological-age testing or longevity technologies, there is something much more fundamental:

The medical history.

A detailed history can reveal information that no single laboratory test can provide.

Dr. Indhira Ghyssaert may consider areas such as:

Previous medical conditions.

Current diagnoses.

Previous surgery.

Medication.

Supplements.

Allergies.

Family medical history.

Diet.

Physical activity.

Sleep.

Smoking.

Alcohol consumption.

Weight changes.

Previous laboratory abnormalities.

Cardiovascular risk factors.

Hormonal and reproductive history where relevant.

Current symptoms.

The objective is to understand the person behind the biomarkers.

Family History and Longevity

Family history can provide valuable information about potential health risks.

Depending on the individual, relevant family history may include:

Premature cardiovascular disease.

Hypertension.

Type 2 diabetes.

Certain cancers.

Osteoporosis.

Neurological conditions.

Other inherited or familial disorders.

Having a family history of a particular condition does not mean that the same condition will inevitably develop.

Likewise, having no known family history does not guarantee protection.

But family history can help Dr. Ghyssaert determine which areas deserve closer attention and whether preventive strategies or screening may need to be adapted.

Longevity Blood Tests: What Should Be Measured?

One of the most common questions about longevity medicine in Mallorca is:

Which blood tests should I have?

There is no universal answer.

The appropriate laboratory assessment depends on:

Age.

Sex.

Medical history.

Family history.

Symptoms.

Medication.

Previous results.

Diet.

Lifestyle.

Existing risk factors.

For some patients, relatively conventional laboratory testing may provide substantial useful information.

For others, additional biomarkers may be appropriate.

The goal should not be to create the longest possible list.

It should be to select tests that can contribute meaningfully to understanding the patient.

Complete Blood Count and General Health

A complete blood count can provide information about different blood-cell populations.

Depending on the results and clinical context, it may contribute to the assessment of conditions such as anaemia and other haematological abnormalities.

But even a common test should not be interpreted in isolation.

An abnormal result needs context.

Is it new?

Has it appeared previously?

Could medication influence it?

Are symptoms present?

Does it require repeat testing or further investigation?

Longevity medicine should not turn laboratory values into isolated optimisation targets.

The purpose is to understand what they mean for the patient.

Glucose, HbA1c and Metabolic Health

Glucose metabolism is particularly relevant to preventive and longevity medicine.

Depending on the individual situation, assessment may include markers such as fasting glucose and HbA1c.

These provide different information about glucose regulation.

Results should be interpreted alongside other factors such as:

Body composition.

Diet.

Physical activity.

Family history.

Medication.

Previous results.

Other metabolic risk factors.

A single number rarely tells the entire story.

The objective is to understand the broader metabolic picture.

Insulin and Insulin Resistance

Some patients are particularly interested in fasting insulin and measures associated with insulin resistance.

These can sometimes provide additional metabolic information.

But the interpretation requires context.

Not every patient needs every available metabolic biomarker.

And no single result should automatically be used to label an otherwise healthy person as metabolically unhealthy.

When Dr. Ghyssaert considers insulin resistance relevant, the focus is not merely on improving a laboratory value.

It is on the broader factors that may influence metabolic health.

Nutrition.

Physical activity.

Muscle mass.

Body composition.

Sleep.

Medication where relevant.

Existing medical conditions.

These are the areas where personalised preventive medicine becomes actionable.

Lipid Profile and Cardiovascular Risk

Cholesterol and other circulating lipids are central to cardiovascular risk assessment.

A conventional lipid profile may include measurements such as:

Total cholesterol.

LDL cholesterol.

HDL cholesterol.

Triglycerides.

Depending on the individual clinical situation, additional lipid-related markers may sometimes be considered.

But laboratory values need to be interpreted within overall cardiovascular risk.

Age.

Blood pressure.

Smoking.

Diabetes.

Family history.

Previous cardiovascular disease.

Other relevant factors.

The question is not simply:

“Is my cholesterol inside the laboratory reference range?”

It is:

“What does my lipid profile mean in the context of my overall cardiovascular risk?”

ApoB and Longevity Medicine

Apolipoprotein B, commonly known as ApoB, has received considerable attention within preventive cardiology and longevity medicine.

ApoB reflects the number of circulating atherogenic lipoprotein particles containing apolipoprotein B.

Depending on the patient's cardiovascular profile, it may provide additional information beyond a conventional lipid panel.

However, its usefulness should still be considered within the wider clinical picture.

ApoB is not a "longevity score."

It is one potential cardiovascular risk marker.

For Dr. Ghyssaert, the value of measuring it depends on whether it contributes useful information for that particular patient.

Lipoprotein(a) and Cardiovascular Risk

Lipoprotein(a), often abbreviated as Lp(a), is another cardiovascular marker increasingly discussed within longevity medicine.

Levels are strongly influenced by genetics.

For selected patients, knowing Lp(a) may contribute useful information about cardiovascular risk.

This can be particularly relevant when considering family history or unexplained cardiovascular risk.

Again, the principle remains the same:

The objective is not to collect biomarkers.

It is to identify information that may change how the patient's risk is understood or managed.

Blood Pressure: A Simple but Powerful Longevity Marker

Longevity medicine does not always require sophisticated technology.

Blood pressure is an excellent example.

Hypertension can be present for years without producing obvious symptoms.

Yet blood pressure is highly relevant to cardiovascular, kidney and cerebrovascular health.

A patient may spend considerable amounts of money investigating advanced longevity biomarkers while overlooking persistently elevated blood pressure.

Dr. Indhira Ghyssaert's approach is therefore to give established health risks the attention they deserve.

Newer does not automatically mean more important.

Kidney Function and Healthy Ageing

Kidney health becomes increasingly important when considering long-term health.

Laboratory assessment may provide information about renal function and electrolyte balance.

Kidney function can also influence medical decisions involving:

Medication.

Certain supplements.

Fluid management.

Some intravenous treatments.

Other interventions.

Abnormal kidney markers should therefore not simply be categorised as "longevity abnormalities."

They may require appropriate medical interpretation and, where necessary, further investigation.

Liver Health and Longevity Medicine

The liver performs essential roles in metabolism and numerous other physiological processes.

Laboratory tests can provide information about different aspects of liver health.

Abnormal liver markers can occur for many reasons.

Metabolic conditions.

Medication.

Alcohol.

Infection.

Other liver or systemic conditions.

If an abnormality is identified, the objective should not simply be to recommend a "detox."

It should be to understand why the abnormality may be present and whether additional evaluation is required.

Thyroid Function and Longevity

Thyroid hormones influence metabolism and multiple physiological systems.

Symptoms associated with thyroid dysfunction can overlap with complaints commonly discussed in longevity medicine, including:

Fatigue.

Changes in body weight.

Changes in temperature tolerance.

Altered bowel habits.

Changes in heart rate.

Mood or cognitive symptoms.

But these symptoms are not specific to thyroid disease.

Where clinically relevant, Dr. Ghyssaert may consider thyroid evaluation as part of a broader assessment.

The objective is to diagnose and manage genuine thyroid dysfunction appropriately—not to push thyroid hormone levels toward arbitrary "optimal" values.

Nutritional Status and Longevity

Adequate nutrition is fundamental to health.

Depending on diet, symptoms, medical history and other factors, Dr. Ghyssaert may consider whether particular nutritional deficiencies warrant investigation.

Examples may include selected vitamins, minerals or other nutritional markers when clinically relevant.

But nutritional testing should follow the same principle as every other aspect of longevity medicine:

Test for a reason.

The existence of a laboratory test does not automatically create a need to perform it.

And the existence of a nutrient in the body does not mean higher levels are always better.

Vitamin D and Healthy Ageing

Vitamin D has received enormous attention within preventive and longevity medicine.

It plays established physiological roles, including in bone and mineral metabolism.

Deficiency or inadequate status may require appropriate consideration depending on the patient.

However, vitamin D should not be treated as a universal anti-ageing therapy.

More is not automatically better.

When testing or supplementation is appropriate, the objective should be to address a meaningful nutritional or medical issue rather than pursue increasingly high levels without clinical justification.

Iron, Ferritin and Fatigue

Iron status can be particularly relevant in patients experiencing fatigue or in individuals with risk factors for iron deficiency.

But interpretation requires care.

Iron deficiency can have multiple causes.

Dietary intake.

Blood loss.

Menstruation.

Gastrointestinal factors.

Other medical conditions.

Identifying iron deficiency should therefore lead to two questions:

Does it need to be corrected?

and

Why did it develop?

Simply replacing iron without considering the cause can miss important clinical information.

Inflammation Markers and Longevity

Inflammatory biomarkers are frequently marketed as indicators of biological ageing.

The reality is more nuanced.

Inflammatory markers can change for many reasons.

Acute infection.

Chronic inflammatory disease.

Recent exercise.

Other medical conditions.

And numerous physiological factors.

A result therefore needs context.

For Dr. Ghyssaert, the purpose of measuring an inflammatory marker is not to assign a patient an "inflammation score."

It is to answer a clinically relevant question.

Hormonal Testing: More Is Not Always Better

Hormone panels are frequently included in longevity programmes.

Sometimes they are appropriate.

Sometimes they are not.

Hormones fluctuate according to numerous factors, including:

Age.

Sex.

Time of day.

Menstrual cycle.

Menopausal status.

Medication.

Illness.

Sleep.

Other physiological variables.

For this reason, hormonal results require appropriate interpretation.

Dr. Ghyssaert does not consider the goal of longevity medicine to be maximising every hormone associated with youth.

The objective is to identify clinically meaningful endocrine problems and manage them appropriately.

Cortisol and Stress

Cortisol is often described as the "stress hormone."

That description is incomplete.

Cortisol is an essential hormone involved in numerous physiological functions and follows a natural daily rhythm.

Stress can influence cortisol, but interpreting cortisol measurements requires context.

A single result does not provide a complete measurement of how "stressed" a person is.

Where cortisol testing is medically relevant, it should be selected and interpreted according to the clinical question rather than used as a general wellness score.

Body Composition and Longevity

Body weight alone provides limited information.

Two people can weigh exactly the same and have very different body compositions.

Longevity medicine may therefore consider:

Muscle mass.

Fat mass.

Central adiposity.

Physical strength.

Overall functional capacity.

The objective is not simply to achieve the lowest possible body weight.

Maintaining adequate muscle while managing excess adiposity where relevant can be particularly important for long-term metabolic and physical health.

Visceral Fat and Metabolic Risk

Fat distribution matters.

Visceral adipose tissue refers to fat located around internal abdominal organs.

Excess visceral adiposity can be associated with metabolic and cardiovascular risk.

This is one reason why BMI alone cannot provide a complete assessment of metabolic health.

However, body-composition measurements should still be interpreted within the wider clinical picture.

A scan or measurement is useful when it contributes to understanding risk and guiding an appropriate intervention.

Muscle Mass: A Longevity Priority

The importance of muscle deserves particular emphasis.

Muscle is not simply relevant to appearance or athletic performance.

It contributes to:

Mobility.

Strength.

Glucose metabolism.

Physical resilience.

Balance.

Functional independence.

Healthy ageing.

Loss of muscle mass and strength can become increasingly important with advancing age.

For this reason, Dr. Indhira Ghyssaert considers maintaining physical capacity a meaningful part of a longevity strategy.

Strength Is a Health Metric

Longevity medicine often focuses heavily on blood tests.

But function matters too.

Can the patient maintain strength?

Can they move comfortably?

Can they perform daily activities?

Are they becoming progressively less active?

Has physical capacity declined?

These questions can provide information that cannot be obtained from a blood sample.

A comprehensive longevity approach therefore looks beyond laboratory values.

Cardiovascular Fitness and VO2 Max

Cardiorespiratory fitness is strongly relevant to overall health and physical capacity.

VO2 max is a measure of maximal oxygen utilisation during exercise and is often discussed in longevity medicine.

It can provide useful information about cardiorespiratory fitness.

But again, a number should not become the sole objective.

For many patients, the more important goal is to improve physical activity and cardiovascular fitness safely and progressively.

Testing can help quantify capacity in selected situations, but it does not replace exercise itself.

Exercise as Longevity Medicine

Few interventions discussed in longevity medicine have the breadth of established health benefits associated with regular physical activity.

A balanced approach may include different forms of movement depending on the individual:

Aerobic exercise.

Resistance training.

Mobility.

Balance.

Daily movement.

Recovery.

The appropriate programme depends on age, fitness, medical history, injuries and objectives.

The goal is not simply athletic performance.

It is maintaining physical capacity over time.

Protein, Nutrition and Muscle Preservation

Adequate nutrition is important for maintaining muscle.

Protein requirements can vary according to:

Age.

Body composition.

Physical activity.

Overall energy intake.

Medical conditions.

Dietary pattern.

A longevity nutrition strategy should therefore consider whether the patient is eating adequately to support their physical objectives.

More protein is not automatically better for every individual.

But inadequate nutritional intake can undermine efforts to preserve muscle and physical function.

Sleep as a Longevity Biomarker

Sleep cannot be completely reduced to a laboratory value.

Yet it can provide important information about health and wellbeing.

Dr. Ghyssaert may ask about:

Sleep duration.

Sleep quality.

Frequent waking.

Difficulty falling asleep.

Daytime sleepiness.

Snoring.

Morning headaches.

Other relevant symptoms.

When clinically indicated, symptoms may warrant further assessment rather than simply adding a sleep supplement.

Sleep Apnoea and Long-Term Health

Obstructive sleep apnoea is an important example of why symptoms should not simply be labelled as "poor recovery."

Patients may experience:

Loud snoring.

Witnessed pauses in breathing.

Daytime sleepiness.

Morning headaches.

Poor-quality sleep.

Other symptoms.

Where there is reasonable clinical suspicion, appropriate assessment may be more important than attempting to optimise sleep through supplements alone.

Longevity medicine should remain connected to ordinary medical diagnosis.

Preventive Screening and Longevity

A serious longevity strategy should not overlook established preventive screening.

Depending on age, sex, family history and individual risk, appropriate screening may include consideration of areas such as:

Cardiovascular risk.

Certain cancers.

Bone health.

Metabolic disease.

Other age-appropriate preventive measures.

The exact screening strategy should be individualised.

The central principle is that early detection of clinically important disease may be far more valuable than measuring dozens of experimental longevity biomarkers.

Cancer Screening and Longevity Medicine

Cancer prevention and early detection are understandably important to people interested in longevity.

However, more screening is not automatically better.

Screening tests have potential benefits but can also involve:

False positives.

False negatives.

Incidental findings.

Overdiagnosis.

Additional procedures.

Anxiety.

The appropriate approach depends on the type of cancer, patient age, sex, family history and individual risk.

Dr. Ghyssaert's approach is therefore to consider established screening principles and individual circumstances rather than indiscriminately testing for everything.

Genetic Testing and Longevity

Genetic testing has become increasingly accessible.

Genetics can provide important medical information in selected circumstances.

But having a genetic variant associated with increased risk does not always mean that disease will develop.

Likewise, favourable genetics do not guarantee long life or protection from chronic disease.

When genetic information is considered, it should be interpreted carefully and within context.

A genetic result should not become a destiny statement.

The practical question remains:

Does this information meaningfully change prevention, screening or medical management?

Epigenetic Age Testing

Epigenetic testing is one of the technologies most strongly associated with modern longevity medicine.

Some tests analyse patterns of DNA methylation to estimate biological ageing.

This is an active and scientifically interesting field.

But patients should understand the distinction between:

A research or emerging biomarker

and

an established clinical endpoint.

An epigenetic-age result may provide interesting information, but it should not automatically determine treatment decisions or be interpreted as an exact prediction of lifespan.

Dr. Ghyssaert considers emerging longevity technologies within the context of their current clinical usefulness and limitations.

Wearables and Continuous Health Data

Smartwatches and other wearable technologies can collect increasingly detailed information.

Heart rate.

Physical activity.

Sleep estimates.

Exercise performance.

Heart-rate variability.

Other physiological measurements.

These technologies can help some patients understand patterns and become more engaged with their health.

But they can also generate enormous amounts of data.

Not every fluctuation represents disease.

Not every wearable alert requires medical intervention.

Data becomes useful when it contributes to meaningful decisions rather than constant self-surveillance.

Continuous Glucose Monitoring and Longevity

Continuous glucose monitors have become increasingly popular outside diabetes care.

They can provide detailed information about glucose patterns.

For selected individuals, this information may be useful.

But not every healthy person necessarily requires continuous glucose monitoring.

Normal glucose fluctuates in response to food, exercise, sleep and other physiological factors.

The objective should not be to create a perfectly flat glucose line.

Where CGM is considered, the question should again be:

What useful clinical or behavioural information are we trying to obtain?

Preventive Medicine Before Experimental Medicine

One of the most important principles in Dr. Indhira Ghyssaert's approach to longevity medicine in Mallorca is prioritisation.

It makes little sense to focus on experimental interventions while major established risk factors remain uncontrolled.

For example:

Advanced biological-age testing while hypertension remains untreated.

Complex supplement programmes while smoking continues.

Expensive longevity technologies while physical activity is minimal.

Experimental optimisation while diabetes risk is ignored.

Sophisticated sleep supplements while significant sleep apnoea remains uninvestigated.

The foundations come first.

Longevity Medicine Should Prioritise What Matters Most

Not every abnormality deserves equal attention.

A longevity assessment may identify multiple areas that could theoretically be improved.

But healthcare needs priorities.

Dr. Ghyssaert's role is not simply to produce a long list of optimisation targets.

It is to help determine:

Which findings are medically important?

Which risks are potentially modifiable?

Which interventions have meaningful evidence?

Which issues require further investigation?

Which findings can simply be monitored?

This prioritisation is one of the most important differences between collecting health data and practising medicine.

What Happens After a Longevity Assessment?

A longevity assessment should lead to an understandable plan.

Depending on the individual patient, recommendations may involve:

Nutrition.

Physical activity.

Strength training.

Weight or body-composition management.

Sleep.

Cardiovascular risk management.

Metabolic health.

Correction of identified nutritional deficiencies.

Appropriate medical treatment.

Preventive screening.

Further investigation.

Specialist referral when necessary.

Monitoring selected biomarkers.

The plan should reflect the patient's actual health profile.

Not Every Patient Needs Treatment

This point is important.

A patient can undergo a preventive or longevity assessment and discover that there is no major medical problem requiring treatment.

That is a perfectly valid outcome.

Recommendations may simply focus on maintaining healthy behaviours, improving selected lifestyle factors and following appropriate preventive screening.

Longevity medicine should not create disease where none exists.

Nor should it invent treatment simply to justify the assessment.

When Further Investigation Is More Important Than Optimisation

Sometimes a longevity assessment identifies something that requires ordinary medical investigation.

Persistent anaemia.

Significantly abnormal liver tests.

Unexpected weight loss.

Marked hormonal abnormalities.

Concerning cardiovascular symptoms.

Significant gastrointestinal symptoms.

Other clinically important findings.

In these situations, the priority changes.

The question is no longer:

“How can we optimise this?”

It becomes:

“Why is this happening?”

Appropriate diagnostic medicine takes priority.

When Specialist Referral Is Appropriate

Personalised medicine does not mean one physician should manage every possible medical condition.

If an assessment identifies an issue requiring specialist expertise, referral may be appropriate.

Depending on the finding, this could involve areas such as:

Cardiology.

Endocrinology.

Gastroenterology.

Gynaecology.

Urology.

Neurology.

Sleep medicine.

Other medical specialties.

Recognising when specialist care is appropriate is part of responsible longevity medicine.

The Difference Between Optimisation and Treatment

The word optimisation is used extensively in longevity medicine.

But it can sometimes blur an important distinction.

Medical treatment addresses a defined clinical problem or indication.

Optimisation often refers to attempts to move already-normal biological parameters toward a preferred target.

These are not necessarily equivalent.

Dr. Indhira Ghyssaert does not assume that every laboratory result should be pushed toward an "optimal" number.

Sometimes normal physiology should simply be left alone.

The objective is better health—not perfect-looking laboratory reports.

Healthy Ageing Is Not Perfect Biology

Human biology varies.

Laboratory values fluctuate.

Energy changes.

Sleep changes.

Physical performance changes.

Ageing itself involves biological change.

Longevity medicine should not create the expectation that every biomarker, hormone and physiological measurement can or should remain identical to those of a 25-year-old.

Healthy ageing is not the absence of biological ageing.

It is the preservation of health and function as effectively as reasonably possible.

The Role of Follow-Up in Longevity Medicine

Longevity medicine is not necessarily a one-time snapshot.

Health changes.

Lifestyle changes.

Medication changes.

Age changes.

Risk factors change.

A useful preventive strategy may therefore involve periodic reassessment where appropriate.

But follow-up should also have a purpose.

Repeating every biomarker every few weeks simply because it can be measured does not necessarily improve healthcare.

The frequency of monitoring should depend on what is being followed and why.

Measuring Progress

Progress in longevity medicine should not be defined by one number.

Depending on the individual, meaningful improvements might include:

Better blood pressure control.

Improved glucose regulation.

Improved lipid management.

Greater physical activity.

Increased strength.

Improved body composition.

Better sleep.

Correction of a nutritional deficiency.

Smoking cessation.

Completion of appropriate screening.

Better management of an established medical condition.

Sometimes the most meaningful progress cannot be summarised by a single "biological age."

Longevity Medicine for Men

Men may seek longevity assessment because of concerns about:

Cardiovascular risk.

Metabolic health.

Body composition.

Testosterone.

Energy.

Sleep.

Physical performance.

Family history.

Healthy ageing.

But male longevity medicine should not be reduced to testosterone therapy.

A comprehensive assessment considers the broader determinants of long-term health before deciding whether any specific hormonal investigation is relevant.

Longevity Medicine for Women

Women may seek longevity medicine at different stages of life.

Areas of interest can include:

Metabolic health.

Cardiovascular prevention.

Menopause.

Bone health.

Body composition.

Thyroid health.

Sleep.

Nutrition.

Hormonal symptoms.

Age-appropriate screening.

Dr. Ghyssaert considers these areas within the patient's complete medical context rather than treating women's longevity as simply a hormone programme.

Longevity Medicine After 40

The forties are often when people begin thinking more seriously about long-term health.

Some risk factors that were previously invisible may become more apparent.

Blood pressure may change.

Metabolic markers may change.

Body composition may shift.

Recovery can feel different.

Family medical history may suddenly feel more relevant.

This can be an appropriate time to review preventive health more systematically.

But there is no universal age at which longevity medicine must begin.

Prevention is relevant throughout adult life.

Longevity Medicine After 50

For many people, the priorities of preventive medicine evolve further after 50.

Depending on the individual, greater attention may be given to:

Cardiovascular risk.

Metabolic health.

Muscle and strength.

Bone health.

Menopause.

Prostate health.

Cancer screening.

Sleep.

Medication.

Existing chronic conditions.

Again, the exact strategy depends on the patient.

Age provides context.

It does not determine the entire programme.

Longevity Medicine After 60

Healthy ageing becomes increasingly connected to preserving function.

Strength.

Mobility.

Balance.

Cardiovascular health.

Cognitive health.

Bone health.

Nutrition.

Medication review.

Prevention of chronic disease complications.

Appropriate screening.

At this stage, adding more treatments is not necessarily the goal.

Maintaining independence and reducing avoidable health risks may become increasingly important.

Longevity Medicine for Healthy People

You do not necessarily need to be ill to discuss preventive health.

Some patients seeking a longevity doctor in Mallorca feel completely well.

Their objective may simply be to understand:

Current health status.

Family risk.

Cardiovascular risk.

Metabolic health.

Lifestyle.

Preventive screening.

Areas worth monitoring.

This can be reasonable.

But a preventive consultation should not transform a healthy person into a patient with dozens of invented problems.

The objective is informed prevention—not medicalisation.

Longevity Medicine for People with Existing Conditions

Longevity medicine is also relevant to people who already have established medical conditions.

In this situation, one of the most important longevity strategies may simply be managing those conditions well.

Hypertension.

Diabetes.

Thyroid disease.

Cardiovascular disease.

Metabolic conditions.

Other chronic illnesses.

Novel longevity interventions should not distract from effective management of established disease.

Executive Health and Longevity Medicine

Executives, entrepreneurs and professionals may become interested in longevity because health affects both long-term wellbeing and current performance.

Long working hours.

Travel.

Stress.

Irregular sleep.

Sedentary time.

Poor nutrition.

Alcohol.

Limited recovery.

These factors can accumulate.

A physician-led longevity assessment in Mallorca can provide an opportunity to review health more systematically rather than waiting for a significant problem to appear.

But executive longevity medicine should still remain medicine.

The objective is not simply performance enhancement.

It is understanding and protecting health.

International Patients Seeking Longevity Medicine in Mallorca

Mallorca attracts international residents, professionals and visitors who may wish to use their time on the island to review their health.

Dr. Indhira Ghyssaert provides English-speaking longevity and preventive medical consultations in Mallorca.

For international patients, the process may include reviewing existing medical records and previous laboratory results where available.

This can help avoid unnecessary duplication and provide continuity with investigations already performed elsewhere.

The objective remains the same:

Understand the individual before deciding what additional assessment is actually necessary.

Bringing the Longevity Assessment Together

A longevity assessment can generate information from many different areas.

Medical history.

Family history.

Laboratory biomarkers.

Blood pressure.

Metabolic health.

Cardiovascular risk.

Body composition.

Physical capacity.

Nutrition.

Sleep.

Hormonal health where relevant.

Preventive screening.

The challenge is not collecting this information.

The challenge is deciding what it means.

Dr. Indhira Ghyssaert's role is to bring these pieces together into a coherent medical picture.

Because ultimately, the purpose of longevity medicine is not to create the most complicated health report possible.

It is to answer something much more useful:

What matters most for this individual's long-term health, and what can reasonably be done about it?

Clinical Principle

The best longevity assessment is not necessarily the one that measures the most. It is the one that identifies meaningful risks, places them in context and turns relevant findings into appropriate action.

Physician-Led Longevity Medicine in Mallorca

The growing interest in longevity has created access to extraordinary amounts of health information.

Biomarkers.

Wearables.

Genetic tests.

Biological-age tests.

Supplements.

Hormones.

New technologies.

Emerging therapies.

But more information does not automatically produce better healthcare.

Medical judgement remains essential.

For Dr. Indhira Ghyssaert, longevity medicine in Mallorca is therefore not about pursuing every available intervention.

It is about combining established preventive medicine with personalised assessment and an informed understanding of emerging longevity science.

Measure what matters.

Interpret it in context.

Prioritise meaningful risks.

Intervene where appropriate.

Investigate when necessary.

Refer when specialist care is required.

And avoid unnecessary treatment when there is no meaningful indication.

That is the foundation of a medically responsible approach to longevity medicine, preventive health and healthy ageing in Mallorca.

Longevity Medicine Mallorca: Frequently Asked Questions

Patients searching for longevity medicine in Mallorca are often looking for something more comprehensive than a routine medical check-up.

Some want to understand their cardiovascular and metabolic risk.

Some are interested in healthy ageing.

Others want to review biomarkers, nutrition, body composition, sleep, hormones or family history.

Some feel completely well but want a clearer picture of their long-term health.

For Dr. Indhira Ghyssaert, longevity medicine begins by distinguishing what is genuinely medically meaningful from what is simply fashionable.

The objective is not to create the longest possible list of tests, supplements or treatments.

It is to identify which factors may reasonably influence the patient’s future health and what can appropriately be done about them.

Is Longevity Medicine the Same as Anti-Ageing Medicine?

Not necessarily.

The term anti-ageing medicine is often associated with attempts to slow, reverse or compensate for biological changes associated with ageing.

Longevity medicine can take a different approach.

Rather than framing ageing itself as a disease that must be reversed, physician-led longevity medicine can focus on:

Preventing avoidable disease.

Reducing modifiable risk.

Preserving physical function.

Maintaining metabolic and cardiovascular health.

Supporting cognitive and musculoskeletal health.

Identifying clinically relevant problems early.

Promoting healthy ageing.

Dr. Indhira Ghyssaert does not promise age reversal.

Her approach is centred on healthspan, prevention and personalised medical decision-making.

Can Longevity Medicine Help Me Live Longer?

No physician can guarantee a longer lifespan.

Human longevity is influenced by many factors, including:

Genetics.

Environment.

Medical conditions.

Lifestyle.

Access to healthcare.

Random biological events.

However, several modifiable factors are strongly associated with long-term health.

Managing blood pressure.

Avoiding smoking.

Maintaining physical activity.

Supporting metabolic health.

Managing established disease appropriately.

Following relevant preventive screening.

Maintaining healthy nutrition.

Protecting physical function.

These interventions may reduce important health risks.

The purpose of longevity medicine is therefore not to guarantee more years of life.

It is to help patients make informed decisions that may improve the probability of healthier years of life.

What Is Healthspan?

Healthspan refers to the period of life spent in relatively good health and functional independence.

It is one of the most useful concepts in longevity medicine.

A person may live to an advanced age but experience many years of reduced mobility, multiple chronic conditions or loss of independence.

Another person may remain active and functional until much later in life.

Longevity medicine therefore considers not only survival.

It considers:

Strength.

Mobility.

Cardiovascular health.

Metabolic health.

Brain health.

Bone health.

Quality of life.

Independence.

The goal is to support healthy ageing, not simply maximise a theoretical lifespan.

At What Age Should I Start Thinking About Longevity Medicine?

There is no single correct age.

Preventive healthcare is relevant throughout adult life.

Some patients become interested in longevity medicine in their thirties because of family history.

Others begin in their forties or fifties when metabolic or cardiovascular risk becomes more relevant.

Others seek assessment later in life because they want to preserve strength, mobility and independence.

The appropriate focus changes with age and individual circumstances.

For Dr. Ghyssaert, the more important question is not:

“Am I old enough for longevity medicine?”

It is:

“Are there meaningful health risks or preventive opportunities worth addressing now?”

Is Longevity Medicine Only for Healthy People?

No.

Longevity medicine may be relevant both to people who feel healthy and to those living with established medical conditions.

For someone who feels well, the focus may be prevention, risk assessment and maintenance of health.

For someone with hypertension, metabolic disease, thyroid disease or another chronic condition, one of the most important longevity strategies may be managing that existing condition effectively.

Novel longevity technologies should not distract from high-quality management of established disease.

Do I Need a Full-Body Scan?

Not automatically.

Whole-body imaging is sometimes marketed within longevity programmes as a comprehensive method of finding disease before symptoms develop.

However, imaging can also identify incidental findings that may lead to further investigation, anxiety or procedures without necessarily improving outcomes.

The appropriateness of imaging depends on the clinical question, age, symptoms, risk factors and evidence supporting the test.

Dr. Indhira Ghyssaert does not consider more imaging automatically better.

Diagnostic tests should have a clear purpose.

Do I Need Genetic Testing?

Not necessarily.

Genetic testing can provide important information in selected situations.

But it is not required for every longevity assessment.

Genetic risk is also not destiny.

Many conditions are influenced by complex interactions between genetics, environment and lifestyle.

When genetic testing is considered, the important question is:

Will the result meaningfully change prevention, screening or medical management?

If the answer is unclear, the test may provide interesting information without necessarily improving healthcare decisions.

What About Biological Age Testing?

Biological-age tests are increasingly marketed within longevity medicine.

They may use:

Blood biomarkers.

Epigenetic patterns.

Physiological measures.

Other biological data.

These technologies are scientifically interesting.

However, there is currently no single universally accepted test that completely measures an individual’s true biological age.

Different methods can produce different results.

For this reason, Dr. Ghyssaert interprets biological-age testing cautiously.

A result may contribute information.

It should not be treated as an exact measure of remaining lifespan or a definitive verdict on health.

What About Epigenetic Age Tests?

Epigenetic clocks analyse patterns such as DNA methylation that are associated with chronological ageing.

They represent an important area of ageing research.

But the translation from research biomarker to routine clinical decision-making is still evolving.

A lower or higher epigenetic-age estimate should not automatically lead to a particular treatment.

And a change in an epigenetic score should not automatically be interpreted as literal reversal of human ageing.

Dr. Ghyssaert’s approach is to distinguish interesting emerging science from established clinical tools.

Can Biological Age Be Reversed?

Some biological-age measurements may change after lifestyle or health interventions.

But this should not automatically be described as reversing the entire ageing process.

A more clinically useful objective is to improve established areas of health.

For example:

Reduce elevated cardiovascular risk.

Improve metabolic health.

Increase physical activity.

Improve muscle strength.

Correct a genuine nutritional deficiency.

Treat sleep disorders.

Improve blood pressure.

Stop smoking.

Manage existing disease appropriately.

These are meaningful health improvements regardless of whether a biological-age score changes.

What Biomarkers Matter Most for Longevity?

There is no universal list.

The value of a biomarker depends on the individual.

Depending on medical history and risk factors, clinically useful information may come from areas such as:

Blood pressure.

Glucose regulation.

HbA1c.

Lipid profile.

Kidney function.

Liver function.

Blood-cell status.

Thyroid function.

Selected nutritional markers.

Body composition.

Cardiovascular risk.

Other relevant investigations.

More specialised biomarkers may sometimes add useful information.

But the central principle remains:

Measure what can meaningfully inform prevention or medical decision-making.

Is ApoB Important for Longevity?

ApoB can provide useful information about atherogenic lipoprotein particle number and may be relevant to cardiovascular risk assessment in selected patients.

But ApoB is not a standalone longevity score.

It should be interpreted together with:

Other lipid measurements.

Blood pressure.

Smoking.

Diabetes status.

Family history.

Existing cardiovascular disease.

Other risk factors.

The objective is to understand overall cardiovascular risk, not optimise one biomarker in isolation.

What About Lipoprotein(a)?

Lipoprotein(a), or Lp(a), is strongly influenced by genetics and may provide additional cardiovascular risk information in selected individuals.

It has attracted increasing attention in preventive cardiology.

However, its interpretation belongs within the broader cardiovascular picture.

The value of measuring Lp(a) depends on the individual patient and the question being asked.

What Is the Role of Insulin Resistance in Longevity?

Metabolic health is highly relevant to long-term health.

Insulin resistance may precede prediabetes and type 2 diabetes.

However, it should not become an automatic diagnosis applied to every patient seeking longevity medicine.

Dr. Ghyssaert considers metabolic health using the appropriate combination of:

Clinical history.

Glucose-related markers.

Body composition.

Physical activity.

Family history.

Diet.

Other relevant risk factors.

The objective is to identify clinically meaningful metabolic risk and address it appropriately.

Is Continuous Glucose Monitoring Useful for Longevity?

Continuous glucose monitoring can provide detailed information about glucose patterns.

For some patients, particularly those with diabetes or specific metabolic concerns, this may be very useful.

Interest has also grown among healthy individuals.

However, not every healthy person needs continuous glucose monitoring.

Normal glucose changes after food, exercise and other physiological events.

The goal should not be to eliminate every glucose fluctuation.

Where CGM is used, it should answer a meaningful question rather than create unnecessary anxiety around normal physiology.

Does Longevity Medicine Include Hormone Testing?

It can, when clinically relevant.

Hormones may be assessed when symptoms, age, medical history or other clinical factors justify investigation.

But longevity medicine should not automatically become a programme for maximising hormones associated with youth.

Thyroid hormones.

Sex hormones.

Cortisol.

Other endocrine markers.

These all require interpretation within their physiological context.

Dr. Ghyssaert’s approach is to identify genuine hormonal disorders where appropriate—not to turn normal ageing-related variation into disease.

Is Testosterone Part of Longevity Medicine?

Testosterone may be clinically relevant for some men.

Symptoms of testosterone deficiency, appropriate laboratory testing, medical history and contraindications all matter.

But testosterone therapy should not be presented as a universal anti-ageing or longevity treatment.

The goal is not to maximise testosterone levels.

The goal is to determine whether a clinically meaningful hormonal issue exists and, if so, manage it appropriately.

Is Menopause Part of Longevity Medicine?

Yes, menopause can be highly relevant to long-term women’s health.

It may influence:

Symptoms.

Bone health.

Metabolic health.

Cardiovascular risk.

Sleep.

Body composition.

Sexual health.

A longevity-focused assessment can consider these areas as part of the woman’s overall health.

Where treatment is considered, decisions should remain personalised and based on individual indications, risks and preferences.

What About Bone Health?

Bone health is essential to healthy ageing.

Loss of bone strength can increase fracture risk and potentially affect independence later in life.

Depending on the individual, Dr. Ghyssaert may consider:

Age.

Menopausal status.

Family history.

Previous fractures.

Medication.

Physical activity.

Nutrition.

Vitamin D where clinically relevant.

Other risk factors.

Bone health should be considered alongside cardiovascular and metabolic health—not after them.

Why Muscle Matters So Much for Longevity

Muscle supports more than appearance.

It contributes to:

Mobility.

Strength.

Balance.

Metabolic health.

Resilience.

Functional independence.

Loss of muscle mass and strength can become increasingly relevant with age.

For this reason, a longevity strategy should consider physical function, not simply weight or body fat.

A patient can have a normal BMI and still have poor strength or low muscle mass.

Is Strength Training Important for Healthy Ageing?

For many adults, appropriate resistance training can be a valuable part of maintaining muscle, bone and physical function.

But exercise recommendations should be individualised.

Age.

Medical conditions.

Injuries.

Previous training.

Mobility.

Cardiovascular health.

All may influence the appropriate programme.

Longevity medicine should encourage sustainable physical capacity rather than forcing every patient into the same performance protocol.

What About VO2 Max?

VO2 max is a measure of maximal oxygen utilisation during exercise and is often used as an indicator of cardiorespiratory fitness.

It can provide useful information in selected patients.

But an impressive VO2 max should not become the only goal.

For most individuals, the broader objective is to maintain or improve cardiovascular fitness safely.

The test can help quantify capacity.

It does not replace regular movement and training.

Does Nutrition Affect Longevity?

Yes.

Nutrition is fundamental to health.

But there is no single universally correct longevity diet for everyone.

A personalised nutrition strategy may consider:

Energy needs.

Protein intake.

Fibre.

Micronutrient adequacy.

Body composition.

Metabolic health.

Medical conditions.

Dietary preferences.

Physical activity.

The aim is not to follow the most fashionable longevity diet.

It is to develop a sustainable nutritional pattern appropriate for the individual.

Is Fasting Necessary for Longevity?

Fasting has attracted substantial attention within longevity research and wellness medicine.

Different forms of fasting can influence metabolism.

However, this does not mean fasting is necessary or appropriate for everyone.

The clinical context matters.

Age.

Body composition.

Medication.

Diabetes risk.

Nutritional status.

Exercise demands.

Other medical conditions.

A dietary pattern should support health rather than become a rigid longevity ideology.

What About Supplements for Longevity?

Some supplements have appropriate uses.

Correcting documented deficiencies can be important.

Certain supplements have evidence for specific indications.

But there is no universal longevity supplement stack proven to extend human lifespan.

Large supplement programmes also create additional considerations:

Interactions.

Duplicated ingredients.

Excessive doses.

Cost.

Potential adverse effects.

Dr. Ghyssaert prefers purposeful supplementation rather than supplementation simply because an ingredient is popular within longevity medicine.

Do I Need NAD+ for Longevity?

NAD biology is scientifically interesting and plays an important role in cellular metabolism.

However, the biological importance of NAD does not establish that NAD+ treatment is required for healthy ageing or that intravenous NAD+ has been proven to extend human lifespan.

Emerging longevity treatments should be discussed with realistic expectations and appropriate scientific caution.

Longevity medicine should not be defined by one molecule or one intervention.

Are IV Drips Part of Longevity Medicine?

Intravenous therapy may have appropriate applications in selected clinical circumstances.

But Dr. Indhira Ghyssaert does not consider regular IV treatment a fundamental requirement for longevity.

IV therapy should remain medically indicated and individually assessed.

A longevity strategy should not become an IV subscription programme.

The foundations remain:

Preventive medicine.

Risk-factor management.

Nutrition.

Exercise.

Sleep.

Metabolic health.

Cardiovascular health.

Appropriate screening.

Management of established disease.

What About Metformin for Longevity?

Metformin is an established medication for specific medical indications, particularly type 2 diabetes and related metabolic contexts.

It has also generated interest within ageing research.

However, interest in a medication as a potential longevity intervention should not be confused with an established indication for prescribing it to every healthy person.

Medication decisions require individual assessment of potential benefits, risks and current evidence.

Dr. Ghyssaert does not consider longevity medicine a justification for automatically prescribing medications outside appropriate clinical reasoning.

What About Rapamycin and Other Emerging Longevity Drugs?

Several pharmaceutical compounds are being investigated in ageing research.

This is an exciting scientific field.

But promising research does not automatically establish routine clinical use in healthy individuals.

Potential risks, long-term safety and evidence of meaningful human outcomes all matter.

Emerging interventions should therefore be distinguished from established preventive medicine.

Dr. Ghyssaert’s approach is to remain informed about longevity research while maintaining appropriate scientific caution before translating emerging findings into routine treatment.

Can Longevity Medicine Prevent Dementia?

No medical programme can guarantee prevention of dementia.

However, several aspects of general health are relevant to brain health.

These may include:

Cardiovascular risk.

Blood pressure.

Metabolic health.

Physical activity.

Sleep.

Smoking.

Alcohol.

Hearing.

Social engagement.

Management of relevant medical conditions.

The practical longevity strategy is therefore broader than searching for one brain-health supplement or biomarker.

What About Cancer Prevention?

Cancer risk is influenced by many different factors, and no longevity programme can eliminate it completely.

Evidence-based prevention may include:

Smoking avoidance.

Appropriate vaccination.

Weight management where relevant.

Healthy lifestyle.

Protection from relevant environmental exposures.

Participation in appropriate screening programmes.

The appropriate strategy depends on age, sex, family history and individual risk.

More testing is not always better.

Screening should be targeted and evidence-informed.

Can Longevity Medicine Detect Disease Early?

Preventive medicine can identify certain conditions or risk factors before they cause obvious symptoms.

Examples may include:

Hypertension.

Prediabetes.

Abnormal lipid profiles.

Certain nutritional deficiencies.

Some cancers through appropriate screening.

Other clinically relevant conditions.

But no assessment can guarantee that every future disease will be detected early.

Patients should therefore be cautious of programmes claiming to identify every hidden health risk.

Should Healthy People Be Tested for Everything?

No.

One of the risks of modern longevity medicine is turning healthy people into patients through excessive testing.

Every test has potential limitations.

False positives.

Incidental abnormalities.

Biological variability.

Uncertain clinical significance.

Further procedures.

Anxiety.

The purpose of preventive medicine is not to prove that something is wrong.

It is to identify meaningful risks where appropriate.

What If All My Longevity Tests Are Normal?

That can be a very good outcome.

A normal assessment does not mean the consultation was unnecessary.

It may confirm that major conventional risk factors are currently well controlled.

The focus can then shift toward maintaining health through:

Physical activity.

Nutrition.

Sleep.

Preventive screening.

Healthy body composition.

Continued monitoring where appropriate.

Longevity medicine does not need to invent an abnormality in order to provide value.

How Often Should I Have a Longevity Assessment?

There is no universal schedule.

Frequency depends on:

Age.

Medical history.

Existing conditions.

Risk factors.

Previous results.

Medication.

Changes in symptoms.

The specific parameters being monitored.

Some preventive measures require periodic reassessment.

Others may only need occasional review.

The objective is not constant testing.

It is appropriate follow-up.

What Does Success Look Like in Longevity Medicine?

Success should not be defined only by a biological-age score.

For one patient, success may mean:

Better blood pressure.

For another:

Improved glucose regulation.

For another:

Stopping smoking.

For another:

Increasing muscle strength.

For another:

Improving sleep.

For another:

Completing overdue cancer screening.

For another:

Correcting a nutritional deficiency.

For another:

Managing an established chronic condition more effectively.

The relevant outcome depends on the individual.

Longevity Medicine Mallorca for International Patients

International patients in Mallorca may have medical records, laboratory results and physicians in different countries.

This can make continuity particularly important.

Dr. Indhira Ghyssaert provides English-speaking medical consultations in Mallorca and can review relevant previous medical information as part of a personalised assessment.

Where appropriate, this may help avoid unnecessary duplication of testing and provide a clearer overview of the patient’s current health.

The aim is to build on existing information rather than automatically starting again from zero.

Longevity Medicine for Second-Home Owners in Mallorca

People who spend part of the year in Mallorca may have healthcare split between different countries.

This can create fragmented information.

Blood tests may be performed in one country.

Specialist consultations in another.

Medication may be prescribed elsewhere.

A physician-led longevity assessment can help bring relevant information together and identify which aspects of prevention or follow-up deserve attention while the patient is in Mallorca.

Continuity does not necessarily require all healthcare to occur in one country.

It requires coordination and clear medical reasoning.

Longevity Medicine for Executives and Entrepreneurs

Busy professionals may postpone preventive care because they feel well and have limited time.

Long working hours, frequent travel, poor sleep, irregular meals, alcohol, stress and prolonged sedentary time can accumulate.

For these patients, a longevity medicine assessment in Mallorca can provide an opportunity to review long-term health more systematically.

The objective should remain healthcare—not simply productivity enhancement.

Protecting health ultimately supports both personal wellbeing and professional performance.

Why Choose a Physician-Led Longevity Approach?

Longevity medicine involves increasingly complex information.

Laboratory tests.

Wearables.

Genetic data.

Biological-age reports.

Imaging.

Supplements.

Hormones.

New drugs.

Emerging technologies.

The challenge is not gaining access to information.

The challenge is knowing what deserves attention.

A physician can evaluate:

What is medically important.

What may represent normal variation.

What needs further investigation.

What can be monitored.

What treatment is appropriate.

What intervention is unsupported.

When specialist referral is required.

And when no treatment is necessary.

This is why clinical judgement remains central to longevity medicine.

Dr. Indhira Ghyssaert’s Philosophy of Longevity Medicine

Dr. Indhira Ghyssaert believes that longevity medicine should remain connected to the principles of good clinical medicine.

That means avoiding two extremes.

The first is treating ageing as though every biological change requires medical intervention.

The second is waiting until significant disease develops before paying attention to prevention.

Her approach lies between these extremes.

Understand the patient.

Assess established risk factors.

Identify meaningful opportunities for prevention.

Investigate when clinically useful.

Use evidence-based medicine as the foundation.

Consider emerging longevity science with appropriate caution.

Treat established medical problems appropriately.

Protect physical function and healthspan.

Refer when specialist expertise is required.

And importantly:

Avoid unnecessary intervention when the patient does not need it.

About Dr. Indhira Ghyssaert

Dr. Indhira Ghyssaert is a licensed General Practitioner providing physician-led private medical consultations in Mallorca.

Her clinical interests include:

Preventive medicine.

Personalised healthcare.

Metabolic health.

Cardiovascular prevention.

Nutrition.

Lifestyle medicine.

Healthy ageing.

Long-term risk assessment.

She works with international residents, second-home owners, executives and visitors seeking a comprehensive medical understanding of their health.

Her longevity approach is centred on careful clinical assessment, evidence-informed prevention and realistic discussion of emerging longevity medicine.

Longevity Medicine Mallorca: A Physician-Led Alternative to Age-Reversal Marketing

Longevity medicine has become one of the fastest-growing areas of modern healthcare.

That growth has produced remarkable scientific innovation.

It has also produced increasingly ambitious claims.

Reverse ageing.

Turn back your biological clock.

Optimise every hormone.

Eliminate inflammation.

Detoxify the body.

Extend lifespan.

These messages are attractive because ageing concerns almost everyone.

But medicine should distinguish aspiration from evidence.

Dr. Indhira Ghyssaert takes a different approach to longevity medicine in Mallorca.

No promise of immortality.

No guarantee of age reversal.

No universal supplement stack.

No assumption that every patient needs experimental treatment.

Instead:

Understand current health.

Identify meaningful risks.

Improve what can reasonably be improved.

Protect function.

Prevent where possible.

Treat where necessary.

Monitor appropriately.

This may sound less dramatic than promising to reverse ageing.

But it is considerably more meaningful as medicine.

The Five Pillars of Dr. Indhira Ghyssaert’s Longevity Approach

1. Prevention

Identify clinically meaningful health risks before they become more difficult to manage where possible.

2. Personalisation

Adapt assessment and recommendations to the individual rather than applying one longevity protocol to everyone.

3. Evidence

Use established medical evidence as the foundation while remaining informed about emerging longevity science.

4. Function

Protect strength, mobility, metabolic health, cardiovascular health and independence—not simply laboratory numbers.

5. Clinical Judgement

Use medical reasoning to determine which findings matter, what needs treatment and what can safely be left alone.

Healthspan Before Hype

Many longevity interventions receive attention because they are new.

But new does not automatically mean important.

Some of the most powerful determinants of long-term health remain surprisingly ordinary.

Do not smoke.

Move regularly.

Maintain strength.

Manage blood pressure.

Protect metabolic health.

Eat adequately.

Sleep well.

Follow appropriate screening.

Treat established disease effectively.

Maintain social and psychological wellbeing.

These interventions may lack the excitement of a new molecule or biological-age test.

But they form the foundation upon which any meaningful longevity strategy should be built.

The Future of Longevity Medicine

Longevity science is evolving rapidly.

Research continues into areas such as:

Cellular senescence.

Epigenetics.

Metabolic regulation.

Mitochondrial biology.

Inflammation.

Genomic medicine.

Regenerative medicine.

Novel pharmaceuticals.

Biological-age biomarkers.

Artificial intelligence.

The coming years may produce important advances.

Some current experimental ideas may become established medical interventions.

Others may not.

The role of a physician is therefore not to reject emerging science.

Nor is it to adopt every innovation before its benefits and risks are adequately understood.

It is to evaluate new information critically and determine when it becomes sufficiently meaningful to influence individual patient care.

Artificial Intelligence and Longevity Medicine

Artificial intelligence can increasingly analyse large amounts of health data.

Laboratory results.

Medical history.

Imaging.

Wearable information.

Research literature.

This may eventually enhance preventive medicine substantially.

But AI does not eliminate the need for clinical judgement.

More analysis produces more information.

Someone still needs to determine:

Which finding is meaningful.

Which is incidental.

What the patient actually wants.

Which risks matter most.

What intervention is appropriate.

Whether treatment benefits outweigh risks.

The future of longevity medicine may therefore combine increasingly sophisticated technology with something very traditional:

A physician who understands the patient.

Longevity Medicine Is Ultimately Personal

Statistics describe populations.

Medicine treats individuals.

Two people can share:

The same age.

The same BMI.

The same cholesterol.

The same glucose.

And still have very different health risks, histories and priorities.

This is why longevity medicine should not become a formula.

The patient's:

Medical history.

Family history.

Lifestyle.

Existing disease.

Preferences.

Goals.

Risk tolerance.

All influence the medical conversation.

Personalisation means recognising those differences.

Related Physician Guides

Patients interested in longevity medicine may also explore:

What Is Longevity Medicine?

Longevity Medicine: What Does It Really Mean?

Preventive Medicine in Mallorca

Health Check-Up Mallorca

Functional Medicine Mallorca

Functional Medicine and Chronic Inflammation

Functional Medicine and Thyroid Disorders

Functional Medicine for Chronic Fatigue

General Practitioner Mallorca

English-Speaking Doctor Mallorca

Request a Longevity Medicine Consultation in Mallorca

If you are interested in understanding your long-term health more comprehensively, you may request a consultation with Dr. Indhira Ghyssaert in Mallorca.

The assessment begins with the individual rather than a predetermined longevity package.

Depending on your circumstances, Dr. Ghyssaert may review:

Medical history.

Family history.

Existing medical conditions.

Medication.

Previous laboratory results.

Cardiovascular risk.

Metabolic health.

Nutrition.

Physical activity.

Body composition.

Sleep.

Hormonal health where clinically relevant.

Preventive screening.

Other individual health concerns.

Further investigations may be considered when they can provide clinically useful information.

The objective is not to perform every available longevity test.

It is to identify which aspects of your current health deserve attention and what actions may meaningfully support your future health and function.

Medical Disclaimer

This guide is provided for general educational purposes and does not constitute individual medical advice, diagnosis or treatment.

Longevity medicine is an evolving field, and not all tests, biomarkers, supplements, medications or interventions marketed for longevity have established clinical benefits.

The appropriateness of any investigation or treatment depends on individual medical circumstances and should be discussed with an appropriately qualified physician.

No medical intervention can guarantee increased lifespan, prevention of all disease or reversal of the biological ageing process.

Patients should not discontinue prescribed medication, begin hormonal treatment or undertake significant medical interventions based solely on general longevity information without appropriate medical assessment.

Longevity Medicine Mallorca: The Final Perspective

The desire to live longer is understandable.

But longevity medicine becomes most valuable when the conversation moves beyond lifespan alone.

The more meaningful question is:

How can we increase the probability of remaining healthy, physically capable, mentally engaged and independent as we grow older?

There is no single answer.

No single biomarker.

No single supplement.

No single diet.

No single medication.

No single longevity technology.

Long-term health emerges from the interaction of genetics, environment, lifestyle, medical care and countless biological processes.

Some factors cannot be changed.

Others can.

The role of physician-led longevity medicine is to understand the difference.

For Dr. Indhira Ghyssaert, longevity medicine in Mallorca therefore means identifying what genuinely matters for the individual patient, prioritising established health risks, using preventive medicine intelligently and approaching emerging longevity science with curiosity but also scientific discipline.

The goal is not perfect biology.

It is not immortality.

And it is not to remain biologically 25 forever.

The goal is something more realistic—and ultimately more valuable:

To protect healthspan.

To preserve function.

To reduce avoidable risk.

To detect clinically meaningful problems when possible.

To make informed medical decisions.

And to help patients build the strongest possible foundations for healthier ageing and long-term wellbeing.

Clinical Principle

Longevity medicine is not the pursuit of immortality. It is the disciplined practice of understanding health today so that we can make better decisions for the years ahead.